These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 34185868)

  • 1. SARS-CoV-2 in eight municipalities of the Colombian tropics: high immunity, clinical and sociodemographic outcomes.
    Garay E; Serrano-Coll H; Rivero R; Gastelbondo B; Faccini-Martínez Á; Berrocal J; Pérez A; Badillo M; Martínez-Bravo C; Botero Y; Arrieta G; Calderón A; Galeano K; López Y; Miranda J; Guzmán C; Contreras V; Arosemena A; Contreras H; Brango-Tarra E; Oviedo M; Mattar S
    Trans R Soc Trop Med Hyg; 2022 Feb; 116(2):139-147. PubMed ID: 34185868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Seroprevalence of the SARS-CoV-2 antibody in healthcare workers: a multicentre cross-sectional study in 10 Colombian cities.
    Malagón-Rojas JN; Mercado-Reyes M; Toloza-Pérez YG; Parra Barrera EL; Palma M; Muñoz E; López R; Almentero J; Rubio VV; Ibáñez E; Téllez E; Delgado-Murcia LG; Jimenez CP; Viasus-Pérez D; Galindo M; Lagos L;
    Occup Environ Med; 2022 Jun; 79(6):388-395. PubMed ID: 34740981
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Seroprevalence of SARS-CoV-2 Infection among Occupational Groups from the Bucaramanga Metropolitan Area, Colombia.
    Colmenares-Mejía CC; Serrano-Díaz N; Quintero-Lesmes DC; Meneses L; Salazar Acosta I; Idrovo ÁJ; Sanabria-Echeverry DY; Cordero-Rebolledo H; Castillo V
    Int J Environ Res Public Health; 2021 Apr; 18(8):. PubMed ID: 33920843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidemiological and viral features of a cohort of SARS-CoV-2 symptomatic and asymptomatic individuals in an area of the Colombian Caribbean.
    Mattar S; Martinez-Bravo C; Rivero R; Contreras H; Faccini-Martínez ÁA; Guzman-Teran C; Galeano K; Alvis-Guzman N; Contreras V; Arrieta G; Gonzalez-Tous M; Miranda J; Ospina M; Camargo-Assis F; Mercado-Reyes M; Garay E; Garcia-Perez A; Lopez Y; Tique V
    Ann Clin Microbiol Antimicrob; 2020 Dec; 19(1):58. PubMed ID: 33287846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Seroprevalence of antibodies against to SARS-CoV 2 in umbilical cord blood in two hospital centers in Córdoba and Sucre, Colombia.
    Berrocal J; Tique-Salleg V; Miranda J; Arrieta G; Echeverri D; Peñate G; Spath D; Mattar AS; Mattar S
    J Infect Public Health; 2022 Oct; 15(10):1076-1080. PubMed ID: 36113400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High Prevalence of SARS-CoV-2 in an Indigenous Community of the Colombian Amazon Region.
    Serrano-Coll H; Miller H; Rodríguez-Van Der Hamen C; Gastelbondo B; Novoa W; Oviedo M; Rivero R; Garay E; Mattar S
    Trop Med Infect Dis; 2021 Oct; 6(4):. PubMed ID: 34842834
    [No Abstract]   [Full Text] [Related]  

  • 7. Seroprevalence of exposure to SARS-CoV-2 in domestic dogs and cats and its relationship with COVID-19 cases in the city of Villavicencio, Colombia.
    Jaramillo Hernández DA; Chacón MC; Velásquez MA; Vásquez-Trujillo A; Sánchez AP; Salazar Garces LF; García GL; Velasco-Santamaría YM; Pedraza LN; Lesmes-Rodríguez LC
    F1000Res; 2022; 11():1184. PubMed ID: 37965037
    [No Abstract]   [Full Text] [Related]  

  • 8. Prevalence of SARS-CoV-2 IgG antibodies in an area of northeastern Italy with a high incidence of COVID-19 cases: a population-based study.
    Stefanelli P; Bella A; Fedele G; Pancheri S; Leone P; Vacca P; Neri A; Carannante A; Fazio C; Benedetti E; Fiore S; Fabiani C; Simmaco M; Santino I; Zuccali MG; Bizzarri G; Magnoni R; Benetollo PP; Merler S; Brusaferro S; Rezza G; Ferro A
    Clin Microbiol Infect; 2021 Apr; 27(4):633.e1-633.e7. PubMed ID: 33253941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Seroprevalence of SARS-CoV-2 infection and associated factors among Bangladeshi slum and non-slum dwellers in pre-COVID-19 vaccination era: October 2020 to February 2021.
    Raqib R; Sarker P; Akhtar E; Nurul Huda TM; Haq MA; Roy AK; Hosen MB; Haque F; Chowdhury MR; Reidpath DD; Emdadul Hoque DM; Islam Z; Ahmed S; Ahmed T; Tofail F; Razzaque A
    PLoS One; 2022; 17(5):e0268093. PubMed ID: 35604947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Seroprevalence of SARS-CoV-2 antibodies in over 6000 healthcare workers in Spain.
    Varona JF; Madurga R; Peñalver F; Abarca E; Almirall C; Cruz M; Ramos E; Castellano Vázquez JM
    Int J Epidemiol; 2021 May; 50(2):400-409. PubMed ID: 33434269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The seroprevalence of SARS-CoV-2 in a rural southwest community.
    Santarelli A; Lalitsasivimol D; Bartholomew N; Reid S; Reid J; Lyon C; Wells J; Ashurst J
    J Osteopath Med; 2021 Feb; 121(2):199-210. PubMed ID: 33567087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of initial SARS-CoV-2 seroprevalence in the most affected districts in the municipality of São Paulo, Brazil.
    Tess BH; Granato CFH; Alves MCGP; Pintão MCT; Nunes MC; Rizzatti EG; Reinach FC
    Braz J Infect Dis; 2021; 25(4):101604. PubMed ID: 34416142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Seroprevalence of COVID-19 infection in the Emirate of Abu Dhabi, United Arab Emirates: a population-based cross-sectional study.
    Alsuwaidi AR; Al Hosani FI; Al Memari S; Narchi H; Abdel Wareth L; Kamal H; Al Ketbi M; Al Baloushi D; Elfateh A; Khudair A; Al Mazrouei S; Al Humaidan HS; Alghaithi N; Afsh K; Al Kaabi N; Altrabulsi B; Jones M; Shaban S; Sheek-Hussein M; Zoubeidi T
    Int J Epidemiol; 2021 Aug; 50(4):1077-1090. PubMed ID: 33893483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A population-based study on seroprevalence and factors associated with SARS-CoV-2 infection in Córdoba, Argentina].
    Aballay LR; Coquet JB; Scruzzi GF; Haluszka E; Franchini G; Carreño P; Raboy E; Román MD; Niclis C; Balangero M; Altamirano N; Barbás MG; López L
    Cad Saude Publica; 2022; 38(4):ES219821. PubMed ID: 35544877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serological cross-reactivity using a SARS-CoV-2 ELISA test in acute Zika virus infection, Colombia.
    Faccini-Martínez ÁA; Rivero R; Garay E; García A; Mattar S; Botero Y; Galeano K; Miranda J; Martínez C; Guzmán C; Arrieta G; Contreras H; Kerguelen H; Moscote M; Brango E; Contreras V
    Int J Infect Dis; 2020 Dec; 101():191-193. PubMed ID: 33002616
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Seroprevalence of SARS-CoV-2 Infection in Portugal in May-July 2020: Results of the First National Serological Survey (ISNCOVID-19).
    Kislaya I; Gonçalves P; Barreto M; Sousa R; Garcia AC; Matos R; Guiomar R; Rodrigues AP;
    Acta Med Port; 2021 Feb; 34(2):87-94. PubMed ID: 33641702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nationwide seroprevalence of antibodies to SARS-CoV-2 in asymptomatic population in South Korea: a cross-sectional study.
    Nah EH; Cho S; Park H; Hwang I; Cho HI
    BMJ Open; 2021 Apr; 11(4):e049837. PubMed ID: 33895722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Seroprevalence of anti-SARS-CoV-2 IgG antibodies in the staff of a public school system in the midwestern United States.
    Lopez L; Nguyen T; Weber G; Kleimola K; Bereda M; Liu Y; Accorsi EK; Skates SJ; Santa Maria JP; Smith KR; Kalinich M
    PLoS One; 2021; 16(6):e0243676. PubMed ID: 34111144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Seroprevalence of SARS-CoV-2 in Guilan Province, Iran, April 2020.
    Shakiba M; Nazemipour M; Salari A; Mehrabian F; Nazari SSH; Rezvani SM; Ghasempour Z; Heidarzadeh A; Mansournia MA
    Emerg Infect Dis; 2021 Feb; 27(2):636-638. PubMed ID: 33349310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Seroprevalence of Unidentified SARS-CoV-2 Infection in Hong Kong During 3 Pandemic Waves.
    Boon SS; Wong MCS; Ng RWY; Leung DTM; Chen Z; Lai CKC; Ho WCS; Huang J; Wong BKC; Fung KSC; Chan PKS
    JAMA Netw Open; 2021 Nov; 4(11):e2132923. PubMed ID: 34779848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.